Related Experiment Video
Updated: Oct 3, 2025

Exploring Caspase Mutations and Post-Translational Modification by Molecular Modeling Approaches
Published on: October 13, 2022
Dynamic disequilibrium-based pathogenicity model in mutated pyrin's B30.2 domain-Casp1/p20 complex
Alaaeldin G Fayez1, Ghada Nour Eldeen1, Waheba A Zarouk1
1Molecular Genetics and Enzymology Department, Human Genetics and Genome Research Institute, National Research Centre (NRC), Cairo, Egypt.
Background:
The B30.2 variants lead to most relevant severity forms of familial Mediterranean fever (FMF) manifestations. The B30.2 domain plays a key role in protein-protein interaction (PPI) of pyrin with other apoptosis proteins and in regulation the cascade of inflammatory reactions. Pyrin-casp1 interaction is mainly responsible for the dysregulation of the inflammatory responses in FMF. Lower binding affinity was observed between the mutant B30.2 pyrin and casp1 without the release of the complete pathogenicity mechanism. The aim of this study was to identify the possible effects of the interface pocked residues in B30.2/SPRY-Casp1/p20 complex using molecular mechanics simulation and in silico analysis.
Results:
It was found that Lys671Met, Ser703Ile, and Ala744Ser variants led mainly to shift of the binding affinity (∆G), dissociation constant (Kd), and root mean square deviation (RMSD) in B30.2/SPRY-Casp1/p20 complex leading to dynamic disequilibrium of the p20-B30.2/SPRY complex toward its complex form. The current pathogenicity model and its predicted implementation in the relevant colchicine dosage were delineated.
Conclusion:
The molecular mechanics analysis of B30.2/SPRY-p20 complex harboring Lys671Met, Ser703Ile, and Ala744Ser variants showed dynamic disequilibrium of B30.2/SPRY-casp1/p20complex in context of the studied variants that could be a new computational model for FMF pathogenicity. This study also highlighted the specific biochemical markers that could be useful to adjust the colchicine dose in FMF patients.
Insights
Familial Mediterranean Fever (FMF) variants in B30.2/SPRY-casp1/p20 complexes cause inflammatory dysregulation. Molecular simulations reveal how specific mutations disrupt binding affinity, offering a new FMF pathogenicity model and potential colchicine dosage adjustments.
Area of Science:
- Biochemistry
- Computational Biology
- Molecular Genetics
Background:
- Familial Mediterranean Fever (FMF) is linked to B30.2 variants affecting pyrin's protein-protein interactions (PPI) and inflammatory regulation.
- Pyrin-caspase-1 (casp1) interaction is crucial for inflammatory response; its dysregulation in FMF is associated with lower binding affinity in mutant B30.2 pyrin.
- Understanding the impact of interface residues in the B30.2/SPRY-Casp1/p20 complex is key to elucidating FMF pathogenicity.
Purpose of the Study:
- To investigate the effects of specific B30.2/SPRY-Casp1/p20 interface residues on complex dynamics and binding affinity.
- To develop a computational model for FMF pathogenicity based on molecular mechanics simulations.
- To identify potential biochemical markers for adjusting colchicine dosage in FMF patients.
Main Methods:
- Molecular mechanics simulations were employed to analyze the B30.2/SPRY-Casp1/p20 complex.
- In silico analysis was performed to assess the impact of Lys671Met, Ser703Ile, and Ala744Ser variants.
- Binding affinity (∆G), dissociation constant (Kd), and root mean square deviation (RMSD) were calculated.
Main Results:
- The studied variants (Lys671Met, Ser703Ile, Ala744Ser) significantly altered binding affinity and complex dynamics.
- A shift in binding affinity and dissociation constant indicated dynamic disequilibrium in the p20-B30.2/SPRY complex.
- The findings support a revised pathogenicity model for FMF.
Conclusions:
- Molecular mechanics analysis revealed dynamic disequilibrium in the B30.2/SPRY-casp1/p20 complex for the studied variants, proposing a novel computational model for FMF pathogenicity.
- The study identified specific biochemical markers that may aid in optimizing colchicine treatment for FMF patients.
- These findings contribute to a deeper understanding of FMF pathogenesis and personalized therapeutic strategies.
Related Concept Videos
Caspases
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

